Catalyst

Slingshot members are tracking this event:

Head-to-Head Study of CMX157 vs. Viread for Treating Hepatitis B expected to conclude in the fourth quarter of 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CTRV Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Cmx157, Viread, Hepatitis B, Hbv Infection, Tdf, Tenofovir, Viread